Enlonstobart, a recombinant, fully humanised immunoglobulin G4 monoclonal antibody targeted against programmed cell death protein 1 (PD-1),…
Cadonilimab is a bispecific antibody that targets the PD-1 and CTLA-4 receptors on tumor cells to…
Zimberelimab is an anti-programmed cell death protein-1 (PD-1) monoclonal antibody being developed by Gloria Biosciences, Arcus…
Copyright © 2021-2022 LienTeh.net All rights reserved.
